Mohanty

Biography

Aditya Mohanty joined the Board in 2016. Mr. Mohanty joined our majority shareholder, BioTime, Inc. as its Chief Operating Officer in 2014, and has been its Co-Chief Executive Officer since 2015. Mr. Mohanty previously served in a number of executive positions at Shire plc, including as President/Head Regenerative Medicine from 2013 to 2014, as Senior Vice President, Business and Technical Operations from 2012 to 2013, as Global Franchise Head MPS from 2010 to 2012, and as Vice President of Operations/Product General Manager from 2005 to 2012. Shire plc is a biotechnology company focused on research, development and commercialization of novel biological products for rare diseases. Mr. Mohanty was VP of Manufacturing and Operations at Transkaryotic Therapies, Inc. from 2002 to 2005 when it was acquired by Shire. Before joining Transkaryotic Therapies, Mr. Mohanty held a number of management positions at Baxter Healthcare Corporation, Bioscience Division from 1990 to 2002. Mr. Mohanty currently serves on the Boards of Directors of OncoCyte Corporation, BioTime, Inc. and Cell Cure Neurosciences. Mr. Mohanty received an M.B.A. degree from Saint Mary's College, an M.S. in Chemical Engineering from Clarkson University, and a B. Tech in Chemical Engineering from REC Trichy, in India. Aditya Mohanty joined the Board in 2016. Mr. Mohanty joined our majority shareholder, BioTime, Inc. as its Chief Operating Officer in 2014, and has been its Co-Chief Executive Officer since 2015. Mr. Mohanty previously served in a number of executive positions at Shire plc, including as President/Head Regenerative Medicine from 2013 to 2014, as Senior Vice President, Business and Technical Operations from 2012 to 2013, as Global Franchise Head MPS from 2010 to 2012, and as Vice President of Operations/Product General Manager from 2005 to 2012. Shire plc is a biotechnology company focused on research, development and commercialization of novel biological products for rare diseases. Mr. Mohanty was VP of Manufacturing and Operations at Transkaryotic Therapies, Inc. from 2002 to 2005 when it was acquired by Shire. Before joining Transkaryotic Therapies, Mr. Mohanty held a number of management positions at Baxter Healthcare Corporation, Bioscience Division from 1990 to 2002. Mr. Mohanty currently serves on the Boards of Directors of OncoCyte Corporation, BioTime, Inc. and Cell Cure Neurosciences. Mr. Mohanty received an M.B.A. degree from Saint Mary's College, an M.S. in Chemical Engineering from Clarkson University, and a B. Tech in Chemical Engineering from REC Trichy, in India.

Research Interest

Business & Management